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Monilethrix is an hereditary hair dystrophy recently
shown to be due to mutations in the helix termination
motif of two type II (basic) human hair keratin genes,
hHb1 and hHb6. It has been suggested that mutation
in hHb1 produces a less severe phenotype. We have
studied hair keratin genes and clinical features in 18
unrelated pedigrees of monilethrix from Germany,
Scotland, Northern Ireland, and Portugal, in 13 of
which mutations have not previously been identified.
By examining the rod domains of hHb1, hHb3 and
hHb6, we have identified mutations in nine of the
new pedigrees. We again found the glutamine-lysine
substitution (E413K) in the helix termination motif of
hHb6 in two families, and in another, the correspond-
ing E413K substitution in the hHb1 gene. In four
families a similar substitution E402K was present in a
nearby residue. In addition two novel mutations within
Monilethrix (Mt) is an autosomal dominant hairdystrophy, characterized by typical beaded orfragile hair shafts, and prominent follicular kerat-oses in many patients (Tietze, 1995). Nail defects,often subtle, have been reported (Heydt, 1963;
Tietze, 1995). The effect on scalp hair is variable and even within
families ranges from normality or mild occipital hair loss to near
total alopecia (Birch-Machin et al, 1997). In some cases alopecia
persists throughout life; in others regrowth of apparently normal
hair may occur at the time of puberty or in pregnancy (Alexander
and Grant, 1958).
Following ultrastructural demonstration of vacuolation of cortical
trichocytes (Ito et al, 1990) and defects in the microfibrillar structure
Manuscript received February 4, 1999; revised June 14, 1999; accepted
for publication June 14, 1999.
Reprint requests to: Dr. Bernhard Korge, Klinik und Poliklinik fu¨r
Dermatologie und Venerologie, Universita¨t zu Ko¨ln, 50924 Ko¨ln, Germany.
Email: Bkorge@mac.genetik.uni-koeln.de
Abbreviations: hHb, human hair basic keratin; IF, intermediate filament;
Mt, monilethrix.
0022-202X/99/$14.00 · Copyright © 1999 by The Society for Investigative Dermatology, Inc.
607
the helix initiation motif of hHb6 were found in
Scottish and Portuguese cases, in whom the same
highly conserved asparagine residue N114 was mutated
to histidine (N114H) or aspartic acid (N114D) residues,
respectively. In four other monilethrix pedigrees
mutations in these domains of hHb1, hHb3, and hHb6
were not found. The mutations identified predict a
variety of possible structural consequences for the
keratin molecule. A comparison of clinical features
and severity between cases with hHb1 and hHb6
mutations does not suggest distinct effects on pheno-
type, with the possible exception of nail dystrophy,
commoner with hHb1 defects. Other factors are
required to explain the marked variation in clinical
severity within and between cases. Key words: hair
diseases/hair keratins/intermediate filaments/monilethrix,
protein structure. J Invest Dermatol 113:607–612, 1999
of the hair cortex (De Berker et al, 1993), the cysteine-rich ‘‘hard’’
keratins of hair and nail, were good candidate genes for Mt.
Severalgroups reported linkage of Mt to the type II keratin gene
cluster at 12q13 (Healy et al, 1995; Stevens et al, 1996)1 where the
human type II hair keratin genes also reside (Rogers et al, 1995).
Subsequently, several groups identified point mutations in the basic
hair keratins of the hair cortex, hHb1 and hHb6. Mutations in
residue 117 of the 2B domain in hHb6 causing Glu413Lys (E413K)
appear to be the most common (Winter et al, 1997a, b; Korge et al,
1998, 1999),2,3 but Glu413Asp has also been reported (Winter et al,
1997a; Zlotogorski et al, 1998). Mutation in the corresponding
1Korge BP, Richards G, Puenter C, et al: Monilethrix links to the
keratin type II cluster at 12q13 and cloning of a possible candidate gene.
J Invest Dermatol 106:843, 1996 (abstr.)
2Korge BP, Healy E, Traupe H, et al: Monilethrix is caused by mutations
in the helix termination peptide of human type II hair keratin hHb6 in
three families. J Invest Dermatol 109:409, 1997 (abstr.)
3Korge BP, Hamm H, Traupe H, et al: Recurrent point mutations in
human type II hair keratins hHb1 and hHb6: A frequent cause of
monilethrix. Arch Dermatol Res 291:122, 1999 (abstr.)
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Table I. Pedigrees studied and mutations found, by gene
ID Origin Original report Cases Affected gene Mutation
M2 Germany Korge et al, 19961 7 hHb1 E402K
M6 Germany Tietze, 1995 4 hHb1 E402K
M8 N Ireland Not previously reported 3 hHb1 E402K
M11 Germany Tietze, 1995 7 hHb1 E402K
L Scotland Alexander and Grant, 1958 2 hHb1 E413K
D Scotland Birch-Machin et al 1997 5 hHb6 N114H
M9 Portugal Not previously reported 1 hHb6 N114D
S Scotland Alexander and Grant, 1958 17 hHb6 E413Ka
O Scotland Healy et al, 1995 9 hHb6 E413Ka
K England Birch-Machin et al 1997 11 hHb6 E413Ka
M1 Germany Tietze, 1995 1 hHb6 E413Ka
M4 Germany Tietze, 1995 5 hHb6 E413Ka
M10 Scotland Anderson, 1883 6 hHb6 E413K
M12 Germany Not previously reported 6 hHb6 E413K
I Spain Birch-Machin et al 1997 7 Not known
M3 Germany Tietze, 1995 3 Not known
M5 Germany Tietze, 1995 3 Not known
M7 Germany Tietze, 1995 4 Not known
aMutations reported in Korge et al, 1998.
residue in hHb1 (E413K; Winter et al, 1997b)3 has been reported
but E402K (residue 106 of 2B domain) in hHb1 is also found
(Winter et al, 1998).3,4 From knowledge of diseases due to epithelial
keratin mutation, defects in the 1A domains would also be predicted
but have not hitherto been reported. It has been suggested on the
basis of a small pedigree (Winter et al, 1998) that mutations in
hHb1 may produce a less severe phenotype.
Hair keratins and their patterns of expression in humans are less
well understood than epithelial keratins, and the reasons for the
considerable number of hard keratin genes is obscure. As with
epithelial keratins, hair keratin intermediate filaments (IF) are
composed of heterodimers containing paired acidic and basic
keratins, with a highly homologous central rod domain, and
functional specificity conferred by the variable N- and C-terminal
domains. In humans, evidence to date suggests nine acidic and at
least four basic hair keratins (Rogers et al, 1997, 1998), but more
may exist. Four basic keratins have been cloned (Rogers et al,
1995, 1997; Bowden et al, 1998),1 of which human basic hair
keratin 5 (hHb5) is expressed in the proliferative pool of the hair
matrix, and hHb1, hHb3, and hHb6 in the cortex. These genes,
and in particular hHb1 and hHb3, have a very high degree of
sequence homology.
We have previously found the E413K mutation in five families
(Korge et al, 1998). Here, we report the search for mutations in
the rod domain of hHb1, hHb3, and hHb6 in 13 more unrelated
cases or families with Mt. In addition to identifying known types
of mutation in six families, we have found two novel mutations
(N114D and N114H) in a highly conserved asparagine residue
within the helix initiation motif of the 1A domain of hHb6. In
five other Mt cases mutations in the rod domains of hHb1,
hHb3, and hHb6 have not been identified. We discuss the likely
consequences of the known mutations for keratin structure. To
address the possible distinct effects of mutations in different keratins
on phenotype, we have compared the clinical features in previously
and newly reported families with mutations in hHB1 and hHb6.
MATERIALS AND METHODS
Subjects Most of the 18 pedigrees have previously been reported
(Table I); these include the descents of a Scottish pedigree which was the
first to be described (Anderson, 1883). In four of the 13 pedigrees in
4Pearce EG, Smith SK, Bowden PE: Different hair-specific keratin
(hHb6) mutations in two families with monilethrix. J Invest Dermatol
112:593, 1999 (abstr.)
whom mutation had not previously been found, linkage analysis confirmed
or was consistent with linkage to 12q13 (Korge et al, 1998). In all families
most members affected displayed the typical phenotype of beaded and
broken hairs, although in many patients this was limited to the occiput.
Some patients presented only with follicular keratoses, or were known to
be affected only as obligate carriers (Birch-Machin et al, 1997). In two
cases, the presence of a mutant gene was only identified after mutation
analysis. In 54 clinically or genetically confirmed cases, data on the
phenotype of the disease were gathered by personal examination, or where
family members were not accessible, by postal questionnaire. A simple
scale was used to assess severity: apparently normal hair, localized thinning,
generally thinning, or severe alopecia. Severity in childhood was assessed
retrospectively using the same four-point scale. A history of change with
age and pregnancy, and evidence of associated features such as fragile or
soft nails, or follicular keratoses, were also sought.
Mutation detection Linkage and DNA studies were approved by the
local research ethics review committee. DNA was extracted from blood
or salivary samples obtained from family members, and polymerase chain
reaction (PCR) amplification performed by standard methods, using the
Expand Long template PCR system (Boehringer Mannheim, Germany).
The primers were picked from the published sequences (EMBL/GenBank:
No X81420 or Y13621 for hHb1; No X99142 or AJ000263 for hHb6).
Gene region 1 primer – primer
hHb1 exon 1/9 cta tcc tgt cct ctg caa cc cag gag tggg agg ggt ctt t
hHb1 exon 7/9 agt gat gcc cgc tgc aag ct cag gag tgg gag ggg tct tt
hHb3 exon 1/2 gtt cca tcc tct gcc atc tac ggg gct cca ggt tac tct ggc
tcc agc
hHb3 exon 7/9 agt gat gcc cgc tgc aag ct agt ctc aca gtg ctt ctt cca
hHb6 exon 1/7 cac agc gtg tgc gga ggc ctg gtt gca ggg tgg gga ggt
ttt cg ta
hHb6 exon 7 ccc tca gcg atg ccc gct ctg gtt gca ggg tgg gga ggt
gca ag ta
PCR was performed at 94°C, then 35 cycles (94°C, 1 min; 65°C,
1 min; 68°C, 2 min) followed by a 7 min extension at 68°C. After gel
purification of the PCR products obtained, direct sequencing was performed
using 33P-labeled ddNTPs and the PCR Product and Sequencing Kit
(USB/Amersham Life Science, Cleveland, OH).
RESULTS
Codon 413 of hHb6 and hHb1 and codon 402 in hHb1 are
hot spots for mutations in Mt Most mutations reported to
date have been at the end of the 2B domain in the helix termination
motif of cortically expressed hair keratins, and hence we began by
screening these regions of hHb1, hHb3, and hHb6 in the 13
families without known mutation. In two families, one German
(M12) and one British (M10), we again found the E413K substitu-
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Figure 1. Part of DNA sequencing gel showing G to A transversion
(arrow) in 2B domain of hHb1 gene of an affected and unaffected
family member. The glutamic acid to lysine substitution in the mutant
allele due to this point mutation is indicated for both mutations below.
Right side, E402K substitution in family M2; left side, E413K substitution
in family L.
Figure 2. Part of DNA sequencing gel. Left side: A to C transversion
(arrow) in 1A domain of hHb6 gene of an unaffected and affected family
member (family D). The asparagine to histidine substitution in the mutant
allele due to this point mutation is indicated below. Right side: A to G
transversion (lower arrow) in 1A domain of hHb6 gene of an unaffected and
affected family member. The asparagine to aspartic acid substitution in the
mutant allele due to this point mutation is indicate below. The top arrow
indicates a polymorphism which is present in the unaffected and affected
individual of this family. This G to A transversion does not change the
amino acid encoded.
Figure 3. RFLP for the TaqI enzyme in a 1138 bp PCR fragment
amplified from the C-terminus of the hHb1 gene in family M2,
showing incomplete cleavage in affected members due to loss of
the restriction site in the mutant allele. 1% agarose gel.
tion at residue 117 of the 2B helix in hHb6. Fifteen pedigrees or
cases with this mutation have now been reported (Fig 4). In one
Scottish family (L) we found the corresponding substitution E413K
(residue 117 of the 2B helix) in hHb1, the second report of this
mutation in Mt (Fig 1), and in three unrelated German and one
Northern Irish family (M2, M6, M8, M11) an E402K substitution
at residue 106 of the 2B helix (Fig 1). The latter mutation is now
the second most frequently reported in Mt, with a total of six
pedigrees or cases. All the above mutations were found in affected
family members and were absent in 50 alleles of unrelated healthy
control individuals. To date we have not identified disease causing
Figure 4. Schematic diagram of the central a-helical rod domain
summarizing the point mutations reported in Mt. The numbers
relate to the amino acid residue within the keratin chain. The single letter
amino acid code is used to indicate the amino acid substitution. Numbers
in parenthesis refer to the frequency for that mutation reported to date.
The small letters refer to the literature where these mutations were
described: (a) Winter et al (1997a); (b) footnote 2; (c) Korge et al (1998);
(d) footnote 3; (e) Zlotogorski et al (1998); (f) Winter et al (1997b); (g)
Winter et al (1998); (h) this report.
Figure 5. End of the 2B helix of a type I and II hair keratin.
Single line, positive/attractive interaction; double line, negative/repulsive
interaction.
mutation in the helix termination motif of hHb3, but in five
families mutations have yet to be identified.
Two novel mutations at codon 114 in the 1A domain of
hHb6 causing Mt In six families/cases of Mt in whom we failed
to identify mutations in the helix termination motif of cortical
keratins we screened the beginning of the rod domain of hHb1,
hHb3, and hHb6, including the helix initiation motif. Applying
this approach we demonstrated mutations in this domain for the
first time in Mt. In a Scottish family (D) we found an A to C
transversion in the helix initiation motif of hHb6, encoding a
histidine residue in place of asparagine at position 114 (N114H,
residue 8 of the 1A helix). In the Portuguese case (M9) we found
an A to G transversion, encoding a aspartic acid residue in place
of asparagine at the same position (N114D).
BseRI and TaqI-restriction fragment length polymorphism
(RFLP) assay for mutation screening E413K and E402K A
suitable BseRI-RFLP for E413K substitution in hHb1 and hHb6
was used as described (Korge et al, 1998). The 298 bp PCR
fragment contains a cutting site for the restriction enzyme BseR1
which is lost following the G to A transversion. A suitable TaqI-
RFLP for the E402K substitution was used to confirm segregation
of the mutation with the phenotype in the M2 pedigree (Fig 3),
as well as to confirm its absence in 36 normal controls (data not
shown). Using hHb1 7/9 1/– primers the 1138 bp PCR fragment
amplified contains a cutting site in the wild-type allele shortening
the PCR fragment by 122 bp. This site is lost in the affected allele.
The RFLP methods we have developed will be of value in
screening isolated cases or pedigrees for this common pathogenic
mutation.
Clinical consequences of mutations in hHb1 and hHb6 are
similar A comparison of the clinical effects of mutations in hHb1
and hHb6 does not suggest a general differential effect on severity
(Table II). Improvement in hair growth generally occurred early
in puberty, although in one case this was the time of disease onset.
Although a smaller proportion of adults with hHb1 defects had the
most severe alopecia, the spread of severity was otherwise similar,
and there was no statistically significant difference between the
groups. The only feature in which a difference was detected was
the presence of soft or unusually ridged nails, which were signific-
antly more common with hHb1 defects. Almost all the cases,
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Table II. Clinical features in 54 cases of Mt
All Mutated gene
hHb1 hHb6
Sex M:F 24 : 30 10 : 8 14 : 22
Severity – in childhood No obvious defect 5 3 2
Locally (occipital) thin hair 12 4 9
Generally thin hair 11 5 8 n.s.a
Severe alopecia 11 6 7
Data not available 10 – 10
All 55 18 37
Severity – postpubertal No obvious defect 13 5 8
Locally (occipital) thin hair 17 5 10
Generally thin hair 11 4 6 n.s.a
Severe alopecia 7 1 7
All 47 15 32
Improvement with age Age . 11 affected as children 22/42 9/14 13/28 n.s.a
Follicular keratoses 30/54 11/18 19/36 n.s.a
Nail dystrophy 16/54 10/18 6/36 p , 0.01a
Improvement in pregnancy 3/15 0/2 3/13 n.s.a
aFisher’s exact test.
however, were from three German families, and the finding may
reflect observer variation. There was no significant effect of gender
on the likelihood of regrowth, or severity in adulthood.
DISCUSSION
The vast majority of pathogenic mutations in keratin genes lie in
the domains encoding the helix boundary peptides, which are
thought to be critical for higher order assembly of keratin inter-
mediate filaments (Parry and Steinert, 1995). It has been suggested
(Parry, 1995, 1996) that unlike epidermal keratins, hair keratin
molecules in the IF, while maintaining the major overlaps character-
istic of all IF, lack the head-to-tail overlap between similarly
directed molecules. The hard α-keratins are believed instead to be
stabilized by numerous intermolecular disulfide bonds. The helix
termination sequence TYR(R/K)LLEGEE is highly conserved
throughout both epidermal keratins and hair keratins. The recurrent
E413K substitution in hHb6 in 15 of the 28 pedigrees/cases of Mt
in which mutations have been identified supports our earlier
contention that this is a hot spot for mutation (Winter et al, 1997a,
b; Korge et al, 1998; this paper). Equivalent mutations in the
corresponding nucleotide in keratin 2e represent a similarly high
proportion of reported mutations in ichthyosis bullosa of Siemens
(Kremer et al, 1994; McLean et al, 1994; Rothnagel et al, 1994;
Jones et al, 1997). Equivalent mutations have been found also in
the keratin 3 gene in Meesmann’s corneal dystrophy (Irvine et al,
1997), in sporadic epidermolysis bullosa simplex cases (Stephens
et al, 1997; Mu¨ller et al, 1999), and pachyonychia congenita.5
Similar mutations E413K and E402K are apparently common in
hHb1, with the latter predominating to date. The E482K mutation
at position 106 of the 2B domain of the K2e gene is also the cause
of ichthyosis bullosa of Siemens in one case.6 The common
mechanism is likely to be spontaneous deamination of a methylated
cytosine in a CpG dinucleotide giving rise to thymine (Strachan
and Read, 1996). As a result of ineffective mismatch repair the
opposite strand is propagated as adenine instead of guanine.
Protein structural implications of the E413K substitution in
hHb1 and hHb6 The lysine mutation at position 413 corresponds
to residue 117 in the 2B helix of both hair keratins. It is thus
located four residues from the C-terminal end of the coiled-coil
5Smith SK, Nogita T, Hashimoto T, Bowden PE: A novel K17 mutation
in a patient with pachyonychia congenita type 2 (PC-2). J Invest Dermatol
110:618, 1998 (abstr.)
6Pitera R, Pitera JE, Eady R, et al: Novel keratin mutations causing
ichthyosis bullosa of Siemens: phenotype variations and K2e. J Invest
Dermatol 104:632, 1995 (abstr.)
rod domain. In hHb1 and hHb6 the mutant lysine residue (Winter
et al, 1997a; Korge et al, 1998) replaces a glutamic acid residue
which occupies an internal d position in the heptad repeat of the
α-helix. The d position in type I, II, and III intermediate filament
chains is often occupied by glutamic acid residues but never by
lysine residues. In contrast, the a position is frequently occupied
by lysine residues, but rarely by glutamic acid residues. This suggests
that either glutamic acid in the d position stabilizes coiled-coil
formation or that lysine interferes with it. Conversely, it is also
possible that glutamic acid in position d destabilizes the coiled-coil
and that lysine, if it was to occur in this position, would introduce
unrequired stability. Either way the effect of the mutant would be
expected to lead to changes in the intermediate filament assembly
or its stability. Normally, residues 117 and 118 are both occupied
by acidic residues and this leads to a potential destabilizing repulsive
interaction (Fig 5). With the lysine mutation, however, the lysine
is followed by an acidic residue, and this would allow a stabilizing
interaction to be made instead. It is hard to predict the exact effect
of this change only one to two turns from the end of the coiled-
coil, but it would not be surprising if this region of the coiled-coil
in the wild-type sequence was designed to have marginal stability,
thus facilitating its termination or giving it greater flexibility. In
contrast, the mutant form could lead to undesired stability arising
from the lysine in the d position and the extra interchain ionic
interaction that becomes possible. Irrespective of whether the lysine
mutation stabilizes or destabilizes the structure of the keratin
molecule it is absolutely clear that some structural rearrangement
at this point in the rod domain would occur.
Protein structural implications of the E402K substitution in
hHb1 The mutation at position 402 corresponds to position 106
in the 2B helix of hHb1. In the coiled-coil rod domain there are
about nine residues that are almost totally conserved across all types
of intermediate filament chains (Steinert and Parry, unpublished):
one of these is E106. This alone implies the structural/functional
importance of this particular residue. There are two obvious reasons
why this residue has been so highly conserved. The first is that it
forms part of one of only three almost perfectly conserved interchain
ionic interactions across all IF chain types. It occurs between the
glutamic acid in position 106 (position g) and a basic residue in
position 111 (position e) and, very likely, has a special role in
stabilizing the end of the coiled-coil rod domain (see Fig 5). The
mutation results in the removal of two positive interchain ionic
interactions by turning one of them into a repulsive interaction.
Furthermore, in vitro studies with bacterially expressed wild-type
and mutant keratin K5 and K14 chains have been tested in a
stability assay in which the urea concentration at which a dimer
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molecule could be dissociated was measured.7 Molecules where
E106 was replaced dissociated at lower urea concentrations and
formed shorter and more irregularly structured filaments. These
in vitro data provide direct evidence that mutations at this site
severely alter normal IF function. Secondly, the residues around
E106 are part of the so-called trigger motif (Kammerer et al, 1998)
which promote coiled-coil formation. Within this motif glutamic
acid is a required component. Hence, it is hard to think of any
residue that is more likely than E106 to have a detrimental effect
on IF structure when mutated.
Protein structural implications of the two 1A helix mutations
(N114H N114D) in hHb6 The mutation at position 114 corre-
sponds to position 8 in helix 1A of hHb1. This asparagine, which
lies in position e is also one of the nine almost totally conserved
residues in all IF chains (Steinert and Parry, unpublished). As
before, this implies special structural/functional significance, but as
asparagine is not a charged or an apolar residue it seems possible
that its role will be to provide key hydrogen-bonding interactions.
Its role may also be to destabilize marginally the structure, but less
so than for possible alternative conformations. The difference
between asparagine and aspartic acid side chains lies in their relative
charges and hydrogen-bonding capabilities. Whether the extra
charge in aspartic acid stabilizes or destabilizes the end of helix 1A
is not clear. Similarly, it is not possible to state whether the different
hydrogen-bonding possibilities lead to stabilization of the wild-
type or the mutant forms. Related comments are also pertinent to
the asparagine to histidine mutations that occurs in the same
position in helix 1A. In summary, therefore, it is possible either
that asparagine destabilizes the wild-type structure and that the
mutations (aspartic acid and histidine) actually introduce more
stabilizing interactions that were previously possible or that the
diametrically opposite explanation is true. Either way, the IF or
the IF molecules will necessarily have altered stability or structure
between the wild-type and the mutant forms. Keratin mutations
involving position 8 of the 1A domain of K1 or K6a are also the
cause for either epidermolytic hyperkeratosis (Mclean et al, 1994;
Yang et al, 1994) or pachyonychia congenita (Bowden et al, 1995),
respectively.
Genotype/phenotype correlation in Mt Knowledge of other
keratin disorders (McLean and Lane, 1995; Korge and Krieg, 1996)
predicts that defects in either partners in a keratin pair could
produce the Mt phenotype, but to date only type II keratin defects
have been found in Mt. On the basis of one small pedigree, it has
been suggested that the hHb1 mutation may produce a milder,
variant phenotype (Winter et al, 1998). It appears from our data,
however, that essentially the same phenotype can occur with
mutations in either hHb1 and hHb6. Nail defects may be more
common with hHb1 mutation which may explain the prominence
of these in some studies (Heydt, 1963; Tietze, 1995). It is clear,
however, that the large variation in severity of hair dystrophy
(Birch-Machin et al, 1997) applies to defects in either gene. These
findings are intriguing, as they imply that Mt is unlike diseases due
to mutations in epithelial keratins, where clinical phenotype is
strongly determined by the keratin pair affected (Irvine and McLean,
1999). If the high degree of sequence homology between these
genes (Rogers et al, 1997), particularly between hHb3 and hHb1,
even in V domains and intron sequences, implies functional
redundancy, it is further surprising that mutation in only one gene
should have such a profound effect. In situ studies, however,
indicate that whereas hHb1 and hHb3 have similar expression
patterns in the emerging cortex, hHb6 mRNA starts and ends
relatively higher in the emerging hair shaft (Rogers et al, 1997). It
may be that the relative importance of each gene expressed varies
7Wu K, Jang S-I, Idler W, Marekov LN, Parry DAD, Yang JM, Steinert
PM: Conserved ionic pairs essential for the stabilization of coiled-coil
molecules of intermediate filaments. Mol Biol Cell 9(Suppl.):250, 1998
(abstr.)
at different stages in the hair cycle. Hair keratin hHa1 gene
expression has been shown to be downregulated (Bowden et al,
1998) in telogen. We have previously suggested that the periodicity
characteristic of Mt hairs results from a feedback loop in which
dystrophic cortical keratinocytes cause a cytokine response indirectly
modulating hair growth, perhaps switching to a different phase of
the hair cycle, and inducing a corrective response. Perhaps defects
in keratins expressed in differing proportions at different points in
the cycle can initiate the same process of periodic dystrophy at
these different points. The improvement of hair growth with age
in many cases may reflect a change in the proportions or numbers
of the various hair keratin genes being expressed.
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